NASDAQ: FBIO
Fortress Biotech, Inc.
Healthcare · Biotechnology
Per-share valuation inputs need verification
Event dated Dec 31, 2025Market-derived shares outstanding and recent statement shares differ materially. Per-share ratios and valuation outputs may be unreliable until the share base is verified. This sometimes appears with ADRs or provider share-count gaps.
Market Cap
$71.81M
52w High
$4.53
52w Low
$1.66
P/E
9.13
Volume
347.74K
Outstanding Shares
32.20M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 28.16% over the last year. Revenue grew 9.66% over the trailing twelve months. Operating margin moved from -197.3% to -111.02%. Free cash flow grew 17.97% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/S range (92nd percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at -111.02% — continued expansion would be needed to justify the premium. Revenue growth of 9.66% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products.
Valuation
Stock splits
Every 15 shares became 1
Profitability & growth
Analyst consensus
6
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 17, 2026
Q2 FY26 · EPS est -$0.19 · Revenue est $19.41M
View